Header Logo

Connection

Theodore Levin to Male

Back to Details
This is a "connection" page, showing publications Theodore Levin has written about Male.
Theodore Levin
Connection Strength
1.796
Male
  1. Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program. Gastroenterology. 2020 11; 159(5):1695-1704.e1.
    View in: PubMed
    Score: 0.068
  2. Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population. Gastroenterology. 2018 11; 155(5):1383-1391.e5.
    View in: PubMed
    Score: 0.059
  3. Performance of a quantitative fecal immunochemical test for detecting advanced colorectal neoplasia: a prospective cohort study. BMC Cancer. 2018 May 02; 18(1):509.
    View in: PubMed
    Score: 0.058
  4. Diagnosis and predictors of sessile serrated adenoma after educational training in a large, community-based, integrated healthcare setting. Gastrointest Endosc. 2018 Mar; 87(3):755-765.e1.
    View in: PubMed
    Score: 0.055
  5. Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis. JAMA. 2017 Apr 25; 317(16):1631-1641.
    View in: PubMed
    Score: 0.054
  6. Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue. Dig Dis Sci. 2017 03; 62(3):678-688.
    View in: PubMed
    Score: 0.053
  7. Fecal Immunochemical Test (FIT) for Colon Cancer Screening: Variable Performance with Ambient Temperature. J Am Board Fam Med. 2016 11 12; 29(6):672-681.
    View in: PubMed
    Score: 0.052
  8. Beyond Colonoscopy: The Role of Alternative Screening Tests for Colorectal Cancer in Your Practice. Am J Gastroenterol. 2017 01; 112(1):8-10.
    View in: PubMed
    Score: 0.052
  9. Colorectal-cancer screening--coming of age. N Engl J Med. 2013 Sep 19; 369(12):1164-6.
    View in: PubMed
    Score: 0.042
  10. Can You Stop Surveillance After Radiofrequency Ablation of Barrett's Esophagus? A Glass Half Full. Gastroenterology. 2013 Jul; 145(1):39-42.
    View in: PubMed
    Score: 0.041
  11. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer. Clin Gastroenterol Hepatol. 2013 Sep; 11(9):1158-66.
    View in: PubMed
    Score: 0.041
  12. Automated phone and mail population outreach to promote colorectal cancer screening. Am J Manag Care. 2012 Jul; 18(7):370-8.
    View in: PubMed
    Score: 0.039
  13. The importance of choosing colorectal cancer screening tests: comment on "Adherence to colorectal cancer screening". Arch Intern Med. 2012 Apr 09; 172(7):582-3.
    View in: PubMed
    Score: 0.038
  14. Editorial: taking FIT to the people: out of the office and into the mail. Am J Gastroenterol. 2012 Jan; 107(1):108-10.
    View in: PubMed
    Score: 0.037
  15. Diagnosis, comorbidities, and management of irritable bowel syndrome in patients in a large health maintenance organization. Clin Gastroenterol Hepatol. 2012 Jan; 10(1):37-45.
    View in: PubMed
    Score: 0.037
  16. Obesity and the rising incidence of oesophageal and gastric adenocarcinoma: what is the link? Gut. 2007 Nov; 56(11):1493-4.
    View in: PubMed
    Score: 0.028
  17. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med. 2006 Dec 19; 145(12):880-6.
    View in: PubMed
    Score: 0.026
  18. Colonoscopic screening of women for colorectal neoplasia. N Engl J Med. 2005 Aug 25; 353(8):844-6; author reply 844-6.
    View in: PubMed
    Score: 0.024
  19. Incomplete screening flexible sigmoidoscopy associated with female sex, age, and increased risk of colorectal cancer. Gut. 2005 Sep; 54(9):1273-8.
    View in: PubMed
    Score: 0.024
  20. Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease. JAMA Netw Open. 2024 Jul 01; 7(7):e2421019.
    View in: PubMed
    Score: 0.022
  21. Fecal Immunochemical Test Screening and Risk of Colorectal Cancer Death. JAMA Netw Open. 2024 Jul 01; 7(7):e2423671.
    View in: PubMed
    Score: 0.022
  22. Surveillance Colonoscopy Findings in Older Adults With a History of Colorectal Adenomas. JAMA Netw Open. 2024 Apr 01; 7(4):e244611.
    View in: PubMed
    Score: 0.022
  23. Colorectal Cancer Screening After Sequential Outreach Components in a Demographically Diverse Cohort. JAMA Netw Open. 2024 Apr 01; 7(4):e245295.
    View in: PubMed
    Score: 0.022
  24. Factors associated with colorectal cancer screening in a population-based study: the impact of gender, health care source, and time. Prev Med. 2004 Mar; 38(3):276-83.
    View in: PubMed
    Score: 0.022
  25. Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing. Cancer Epidemiol Biomarkers Prev. 2024 Feb 06; 33(2):215-223.
    View in: PubMed
    Score: 0.022
  26. What does sigmoidoscopy really miss? Am J Gastroenterol. 2003 Oct; 98(10):2326-7.
    View in: PubMed
    Score: 0.021
  27. Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas. Gastroenterology. 2013 Aug; 145(2):312-9.e1.
    View in: PubMed
    Score: 0.021
  28. Complications of screening flexible sigmoidoscopy. Gastroenterology. 2002 Dec; 123(6):1786-92.
    View in: PubMed
    Score: 0.020
  29. Could screening for colorectal cancer be harmful? Am J Gastroenterol. 2002 Jan; 97(1):198.
    View in: PubMed
    Score: 0.019
  30. Increased Risk of Colorectal Cancer in Individuals With a History of Serrated Polyps. Gastroenterology. 2020 08; 159(2):502-511.e2.
    View in: PubMed
    Score: 0.017
  31. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology. 2010 Jul; 139(1):93-101.
    View in: PubMed
    Score: 0.017
  32. Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. Gastroenterology. 2020 03; 158(4):884-894.e5.
    View in: PubMed
    Score: 0.016
  33. Colorectal cancer screening: new opportunities. Surg Oncol Clin N Am. 1999 Oct; 8(4):673-91, vi-vii.
    View in: PubMed
    Score: 0.016
  34. Comparison of Universal Versus Age-Restricted Screening of Colorectal Tumors for Lynch Syndrome Using Mismatch Repair Immunohistochemistry: A Cohort Study. Ann Intern Med. 2019 07 02; 171(1):19-26.
    View in: PubMed
    Score: 0.016
  35. Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy. JAMA. 1999 May 05; 281(17):1611-7.
    View in: PubMed
    Score: 0.016
  36. Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death. Gastroenterology. 2019 01; 156(1):63-74.e6.
    View in: PubMed
    Score: 0.015
  37. Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers. Gastrointest Endosc. 2019 01; 89(1):168-176.e3.
    View in: PubMed
    Score: 0.015
  38. Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux. Am J Gastroenterol. 1998 Jul; 93(7):1060-3.
    View in: PubMed
    Score: 0.015
  39. A cost analysis of a Helicobacter pylori eradication strategy in a large health maintenance organization. Am J Gastroenterol. 1998 May; 93(5):743-7.
    View in: PubMed
    Score: 0.015
  40. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev. 2008 Feb; 17(2):352-8.
    View in: PubMed
    Score: 0.014
  41. Costs of acid-related disorders to a health maintenance organization. Am J Med. 1997 Dec; 103(6):520-8.
    View in: PubMed
    Score: 0.014
  42. A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening. Am J Gastroenterol. 2017 Nov; 112(11):1728-1735.
    View in: PubMed
    Score: 0.014
  43. Colorectal Cancer Screening Initiation After Age 50 Years in an Organized Program. Am J Prev Med. 2017 Sep; 53(3):335-344.
    View in: PubMed
    Score: 0.014
  44. Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut. 2007 Jun; 56(6):756-62.
    View in: PubMed
    Score: 0.013
  45. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut. 2018 02; 67(2):291-298.
    View in: PubMed
    Score: 0.013
  46. Endoscopist fatigue estimates and colonoscopic adenoma detection in a large community-based setting. Gastrointest Endosc. 2017 Mar; 85(3):601-610.e2.
    View in: PubMed
    Score: 0.013
  47. Shifts in the Fecal Microbiota Associated with Adenomatous Polyps. Cancer Epidemiol Biomarkers Prev. 2017 01; 26(1):85-94.
    View in: PubMed
    Score: 0.013
  48. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System. J Gen Intern Med. 2016 11; 31(11):1323-1330.
    View in: PubMed
    Score: 0.013
  49. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test. Clin Gastroenterol Hepatol. 2016 10; 14(10):1445-1451.e8.
    View in: PubMed
    Score: 0.013
  50. Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med. 2016 Apr 05; 164(7):456-63.
    View in: PubMed
    Score: 0.012
  51. Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma. BMC Cancer. 2015 Mar 14; 15:123.
    View in: PubMed
    Score: 0.012
  52. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015 Jul 01; 121(13):2281-5.
    View in: PubMed
    Score: 0.012
  53. Radiographic features of anterior buccal mandibular depression in modern human cadavers. Dentomaxillofac Radiol. 1995 Feb; 24(1):46-9.
    View in: PubMed
    Score: 0.012
  54. Development and validation of an algorithm for classifying colonoscopy indication. Gastrointest Endosc. 2015 Mar; 81(3):575-582.e4.
    View in: PubMed
    Score: 0.012
  55. Ten-year incidence of colorectal cancer following a negative screening sigmoidoscopy: an update from the Colorectal Cancer Prevention (CoCaP) programme. Gut. 2016 Feb; 65(2):271-7.
    View in: PubMed
    Score: 0.011
  56. Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol. 2015 Mar; 25(3):208-213.e1.
    View in: PubMed
    Score: 0.011
  57. Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based setting. Clin Gastroenterol Hepatol. 2015 Apr; 13(4):739-46.
    View in: PubMed
    Score: 0.011
  58. Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the U.S. multi-society task force on colorectal cancer. Gastrointest Endosc. 2014 Oct; 80(4):543-562.
    View in: PubMed
    Score: 0.011
  59. Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas. J Natl Cancer Inst. 2004 Sep 15; 96(18):1383-7.
    View in: PubMed
    Score: 0.011
  60. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Dis Colon Rectum. 2014 Aug; 57(8):1025-48.
    View in: PubMed
    Score: 0.011
  61. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2014 Aug; 80(2):197-220.
    View in: PubMed
    Score: 0.011
  62. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014 Apr 03; 370(14):1287-97.
    View in: PubMed
    Score: 0.011
  63. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology. 2003 Sep; 125(3):668-76.
    View in: PubMed
    Score: 0.011
  64. Effectiveness and reach of the FLU-FIT program in an integrated health care system: a multisite randomized trial. Am J Public Health. 2013 Jun; 103(6):1128-33.
    View in: PubMed
    Score: 0.010
  65. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):312-20.
    View in: PubMed
    Score: 0.010
  66. Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology. 2013 Mar; 57(3):881-9.
    View in: PubMed
    Score: 0.010
  67. Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol. 2013 Feb; 11(2):172-80.
    View in: PubMed
    Score: 0.010
  68. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology. 2012 Aug; 143(2):382-9.
    View in: PubMed
    Score: 0.010
  69. Lack of association between insulin sensitivity and colorectal adenoma risk. Nutr Cancer. 2011; 63(1):6-11.
    View in: PubMed
    Score: 0.009
  70. Serial glycosylated hemoglobin levels and risk of colorectal neoplasia among patients with type 2 diabetes mellitus. Cancer Epidemiol Biomarkers Prev. 2010 Dec; 19(12):3027-36.
    View in: PubMed
    Score: 0.009
  71. Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2010 Jan; 8(1):42-48.e1.
    View in: PubMed
    Score: 0.008
  72. Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus. Gastroenterology. 2009 Mar; 136(3):806-15.
    View in: PubMed
    Score: 0.008
  73. Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. Gut. 2009 Feb; 58(2):182-8.
    View in: PubMed
    Score: 0.008
  74. Iron intake and body iron stores as risk factors for Barrett's esophagus: a community-based study. Am J Gastroenterol. 2008 Dec; 103(12):2997-3004.
    View in: PubMed
    Score: 0.007
  75. Helicobacter pylori and gastroesophageal reflux disease: a case-control study. Helicobacter. 2008 Oct; 13(5):352-60.
    View in: PubMed
    Score: 0.007
  76. Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus. Gastroenterology. 2008 Dec; 135(6):1914-23, 1923.e1.
    View in: PubMed
    Score: 0.007
  77. Dietary antioxidants, fruits, and vegetables and the risk of Barrett's esophagus. Am J Gastroenterol. 2008 Jul; 103(7):1614-23; quiz 1624.
    View in: PubMed
    Score: 0.007
  78. Hemochromatosis gene status as a risk factor for Barrett's esophagus. Dig Dis Sci. 2008 Dec; 53(12):3095-102.
    View in: PubMed
    Score: 0.007
  79. Dietary patterns and the risk of Barrett's esophagus. Am J Epidemiol. 2008 Apr 01; 167(7):839-46.
    View in: PubMed
    Score: 0.007
  80. Hepatic effects of lovastatin exposure in patients with liver disease: a retrospective cohort study. Drug Saf. 2008; 31(4):325-34.
    View in: PubMed
    Score: 0.007
  81. Medical therapy for diabetes is associated with increased use of lower endoscopy. Pharmacoepidemiol Drug Saf. 2007 Nov; 16(11):1195-202.
    View in: PubMed
    Score: 0.007
  82. Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut. 2008 Jun; 57(6):727-33.
    View in: PubMed
    Score: 0.007
  83. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst. 2007 Oct 03; 99(19):1462-70.
    View in: PubMed
    Score: 0.007
  84. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007 Jul; 133(1):34-41; quiz 311.
    View in: PubMed
    Score: 0.007
  85. Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis. 2007 Aug; 28(8):1672-9.
    View in: PubMed
    Score: 0.007
  86. Change in body size and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2007 Mar; 16(3):526-31.
    View in: PubMed
    Score: 0.007
  87. Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer. 2007 Feb 01; 120(3):656-63.
    View in: PubMed
    Score: 0.007
  88. Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Clin Gastroenterol Hepatol. 2006 Jul; 4(7):894-901.
    View in: PubMed
    Score: 0.006
  89. Barrett's esophagus and medications that relax the lower esophageal sphincter. Am J Gastroenterol. 2006 May; 101(5):937-44.
    View in: PubMed
    Score: 0.006
  90. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2006 May; 130(6):1865-71.
    View in: PubMed
    Score: 0.006
  91. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology. 2006 May; 130(6):1872-85.
    View in: PubMed
    Score: 0.006
  92. PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States). Cancer Causes Control. 2006 Apr; 17(3):239-49.
    View in: PubMed
    Score: 0.006
  93. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology. 2005 Sep; 129(3):837-45.
    View in: PubMed
    Score: 0.006
  94. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res. 2005 Jul 15; 65(14):6063-9.
    View in: PubMed
    Score: 0.006
  95. Associations between apoE genotype and colon and rectal cancer. Carcinogenesis. 2005 Aug; 26(8):1422-9.
    View in: PubMed
    Score: 0.006
  96. CYP1A1, cigarette smoking, and colon and rectal cancer. Am J Epidemiol. 2004 Nov 01; 160(9):842-52.
    View in: PubMed
    Score: 0.006
  97. The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology. 2004 Sep; 127(3):714-22.
    View in: PubMed
    Score: 0.006
  98. Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway. Cancer Epidemiol Biomarkers Prev. 2004 Apr; 13(4):538-45.
    View in: PubMed
    Score: 0.005
  99. Family history and colorectal cancer: predictors of risk. Cancer Causes Control. 2003 Nov; 14(9):879-87.
    View in: PubMed
    Score: 0.005
  100. A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease. Arch Intern Med. 2003 May 26; 163(10):1165-71.
    View in: PubMed
    Score: 0.005
  101. Gastric and duodenal safety of daily alendronate. Arch Intern Med. 2002 Apr 22; 162(8):936-42.
    View in: PubMed
    Score: 0.005
  102. Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study. J Clin Epidemiol. 2002 Mar; 55(3):310-3.
    View in: PubMed
    Score: 0.005
  103. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology. 2002 Mar; 122(3):633-40.
    View in: PubMed
    Score: 0.005
  104. Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia. Am J Gastroenterol. 2001 Feb; 96(2):338-47.
    View in: PubMed
    Score: 0.004
  105. Use of complementary medicine by adult patients participating in cancer clinical trials. Oncol Nurs Forum. 2000 May; 27(4):623-30.
    View in: PubMed
    Score: 0.004
  106. Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am J Gastroenterol. 2000 Mar; 95(3):788-92.
    View in: PubMed
    Score: 0.004
  107. Acute and late outcome after use of 2.5-mm intracoronary stents in small (< 2.5 mm) coronary arteries. Catheter Cardiovasc Interv. 2000 Feb; 49(2):121-6.
    View in: PubMed
    Score: 0.004
  108. Cardiac exposure history as a determinant of symptoms and emergency department utilization in noncardiac chest pain patients. J Behav Med. 1999 Dec; 22(6):605-17.
    View in: PubMed
    Score: 0.004
  109. Spontaneous peritonitis caused by Streptococcus bovis. J Clin Gastroenterol. 1994 Dec; 19(4):346.
    View in: PubMed
    Score: 0.003
  110. Malignant fibrous histiocytoma arising in a scar. Eur J Surg Oncol. 1988 Feb; 14(1):83-6.
    View in: PubMed
    Score: 0.002

© 2024 Kaiser Permanente